Cottage Street Advisors LLC Amgen Inc Transaction History

Cottage Street Advisors LLC

$184 Billion
Q3 2024

A detailed history of Cottage Street Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Cottage Street Advisors LLC holds 2,485 shares of AMGN stock, worth $657,257. This represents 0.44% of its overall portfolio holdings.

Number of Shares

2,485

Previous 2,483 0.08%

Holding current value

$657,257

Previous $776 Million 3.18%

% of portfolio

0.44%

Previous 0.46%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $618 - $674	2 Added 0.08%	2,485 $801 Million
Q2 2024 Jul 23, 2024	BUY	$262.75 - $319.31 $262 - $319	1 Added 0.04%	2,483 $776 Million
Q1 2024 Apr 22, 2024	BUY	$268.87 - $324.56 $9,679 - $11,684	36 Added 1.47%	2,482 $706 Million
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $26,675 - $33,118	122 Added 5.25%	2,446 $657 Million
Q2 2023 Jul 24, 2023	BUY	$214.27 - $253.37 $214 - $253	1 Added 0.04%	2,324 $516 Million
Q1 2023 Apr 21, 2023	BUY	$225.79 - $275.2 $524,510 - $639,289	2,323 New	2,323 $562 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $224 - $253	1 Added 0.04%	2,322 $523,000
Q1 2022 Apr 20, 2022	BUY	$219.27 - $242.57 $219 - $242	1 Added 0.04%	2,321 $561,000
Q4 2021 Jan 13, 2022	BUY	$198.88 - $227.6 $7,358 - $8,421	37 Added 1.62%	2,320 $522,000
Q3 2021 Oct 12, 2021	BUY	$212.27 - $248.7 $13,160 - $15,419	62 Added 2.79%	2,283 $485,000
Q2 2021 Jul 20, 2021	BUY	$233.58 - $259.14 $3,036 - $3,368	13 Added 0.59%	2,221 $541,000
Q1 2021 Apr 22, 2021	BUY	$221.91 - $258.6 $1,775 - $2,068	8 Added 0.36%	2,208 $549,000
Q3 2020 Oct 08, 2020	SELL	$234.65 - $260.95 $93,860 - $104,380	-400 Reduced 15.38%	2,200 $559,000
Q2 2020 Jul 09, 2020	SELL	$197.81 - $242.74 $10,879 - $13,350	-55 Reduced 2.07%	2,600 $613,000
Q3 2019 Oct 24, 2019	BUY	$174.11 - $208.62 $174 - $208	1 Added 0.04%	2,655 $514,000
Q2 2019 Aug 02, 2019	SELL	$166.7 - $195.41 $227,712 - $266,930	-1,366 Reduced 33.98%	2,654 $489,000
Q1 2019 May 01, 2019	BUY	$180.87 - $203.88 $180 - $203	1 Added 0.02%	4,020 $764,000
Q3 2018 Nov 05, 2018	SELL	$185.29 - $208.89 $83,380 - $94,000	-450 Reduced 10.07%	4,019 $832,000
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $672,336 - $755,178	-4,049 Reduced 47.53%	4,469 $825,000
Q1 2018 Apr 27, 2018	SELL	$169.43 - $198.0 $93,186 - $108,900	-550 Reduced 6.07%	8,518 $1.45 Million
Q4 2017 Jan 16, 2018	SELL	$168.79 - $188.59 $127,267 - $142,196	-754 Reduced 7.68%	9,068 $1.58 Million
Q3 2017 Oct 17, 2017	BUY	$167.29 - $191.0 $1.64 Million - $1.88 Million	9,822	9,822 $1.83 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cottage Street Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cottage Street Advisors LLC with notifications on news.

Account

Cottage Street Advisors LLC Amgen Inc Transaction History